Alfonseca-Silva, Edgar
(Department of Microbiology and Immunology, School of Veterinary Medicine, National Autonomous University of Mexico)
Cruz-Villa, Juan Carlos (Department of Microbiology and Immunology, School of Veterinary Medicine, National Autonomous University of Mexico) Gutierrez, Lilia (Department of Physiology and Pharmacology, School of Veterinary Medicine, National Autonomous University of Mexico) Sumano, Hector (Department of Physiology and Pharmacology, School of Veterinary Medicine, National Autonomous University of Mexico) |
1 | Sumano H, Ocampo L, Tapia G, Mendoza CJ, Gutierrez L. Pharmacokinetics of enrofloxacin HCl-2H 2 O (Enro-C) in dogs and pharmacokinetic/pharmacodynamic Monte Carlo simulations against Leptospira spp. J Vet Sci. 2018;19(5):600-607. DOI |
2 | Suojala L, Simojoki H, Mustonen K, Kaartinen L, Pyorala S. Efficacy of enrofloxacin in the treatment of naturally occurring acute clinical Escherichia coli mastitis. J Dairy Sci. 2010;93(5):1960-1969. DOI |
3 | Kaartinen L, Salonen M, Alli L, Pyorala S. Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows. J Vet Pharmacol Ther. 1995;18(5):357-362. DOI |
4 | Ocampo PS, Lazar V, Papp B, Arnoldini M, Abel zur Wiesch P, Busa-Fekete R, et al. Antagonism between bacteriostatic and bactericidal antibiotics is prevalent. Antimicrob Agents Chemother. 2014;58(8):4573-4582. DOI |
5 | Owens WE, Nickerson SC, Ray CH. Efficacy of parenterally or intramammarily administered tilmicosin or ceftiofur against Staphylococcus aureus mastitis during lactation. J Dairy Sci. 1999;82(3):645-647. DOI |
6 | Sharma N, Singh NK, Bhadwal MS. Relationship of somatic cell count and mastitis: an overview. AsianAustralas J Anim Sci. 2011;24(3):429-438. |
7 | Jimenez Mejia R, Gudino Sosa LF, Aguilar Lopez JA, Loeza Lara PD. Molecular characterization of antibiotic resistant Escherichia coli isolated from bovine mastitis in Michoacan, Mexico. Rev Mex Cienc Pecu. 2017;8(4):387-396. DOI |
8 | Mendoza J, Gutierrez L, Gutierrez JA, Bustos FA, Sumano H. Pharmacokinetics of enrofloxacin HCl-2H2 O (ENRO-C), PK/PD, and Monte Carlo modeling vs. Leptospira spp. in cows. J Vet Pharmacol Ther. 2019;42(3):300-308. DOI |
9 | Yang B, Lei Z, Zhao Y, Ahmed S, Wang C, Zhang S, et al. Combination susceptibility testing of common antimicrobials in vitro and the effects of sub-MIC of antimicrobials on Staphylococcus aureus biofilm formation. Front Microbiol. 2017;8:2125. DOI |
10 | Carter GR, Cole JR. Diagnostic Procedure in Veterinary Bacteriology and Mycology. 5th ed. Cambridge: Academic Press; 1990. |
11 | Galfi A, Radinovic M, Milanov D, Bobos S, Pajic M, Savic S, et al. Electrical conductivity of milk and bacteriological findings in cows with subclinical mastitis. J Anim Sci Biotechnol. 2015;31(4):533-541. |
12 | Krishnamoorthy P, Satyanarayana ML, Shome BR. Coagulase negative Staphylococcal species mastitis: an overview. Res J Vet Sci. 2016;9(1):1-10. |
13 | Pyorala S, Taponen S. Coagulase-negative staphylococci-emerging mastitis pathogens. Vet Microbiol. 2009;134(1-2):3-8. DOI |
14 | Majlesi A, Kakhki RK, Mozaffari Nejad AS, Mashouf RY, Roointan A, Abazari M, et al. Detection of plasmid-mediated quinolone resistance in clinical isolates of Enterobacteriaceae strains in Hamadan, West of Iran. Saudi J Biol Sci. 2018;25(3):426-430. DOI |
15 | Chavez-Jacobo VM, Ramirez-Diaz MI, Silva-Sanchez J, Cervantes C. Resistencia bacteriana a quinolonas: determinantes codificados en plasmidos. Rev Educ Bioquim. 2015;34(1):4-9. |
16 | Ruegg PL. A 100-year review: mastitis detection, management, and prevention. J Dairy Sci. 2017;100(12):10381-10397. DOI |
17 | Izquierdo AC, Liera JEG, Cervantes RE, Castro JFI, Mancera EAV, Crispin RH, et al. Production of milk and bovine mastitis. J Adv Dairy Res. 2017;5(2):1-4. |
18 | Ashraf A, Imran M. Diagnosis of bovine mastitis: from laboratory to farm. Trop Anim Health Prod. 2018;50(6):1193-1202. DOI |
19 | Kumari T, Bhakat C, Choudhary RK. A review on sub clinical mastitis in dairy cattle. Int J Pure Appl Biosci. 2018;6(2):1291-1299. |
20 | Ciesielczuk H, Hornsey M, Choi V, Woodford N, Wareham DW. Development and evaluation of a multiplex PCR for eight plasmid-mediated quinolone-resistance determinants. J Med Microbiol. 2013;62(Pt 12):1823-1827. DOI |
21 | Qin T, Qian H, Fan W, Ma P, Zhou L, Dong C, et al. Newest data on fluoroquinolone resistance mechanism of Shigella flexneri isolates in Jiangsu Province of China. Antimicrob Resist Infect Control. 2017;6(1):97. DOI |
22 | Correia S, Poeta P, Hebraud M, Capelo JL, Igrejas G. Mechanisms of quinolone action and resistance: where do we stand? J Med Microbiol. 2017;66(5):551-559. DOI |
23 | Persson Y, Katholm J, Landin H, Mork MJ. Efficacy of enrofloxacin for the treatment of acute clinical mastitis caused by Escherichia coli in dairy cows. Vet Rec. 2015;176(26):673. DOI |
24 | Gutierrez L, Miranda-Calderon JE, Garcia-Gutierrez P, Sumano H. Physicochemical characterization and pharmacokinetics in broiler chickens of a new recrystallized enrofloxacin hydrochloride dihydrate. J Vet Pharmacol Ther. 2015;38(2):183-189. DOI |
25 | Sayeed MA, Rahman MA, Bari MS, Islam A, Rahman MM, Hoque MA. Prevalence of subclinical mastitis and associated risk factor at cow level in dairy farms in Jhenaidah. Adv Anim Vet Sci. 2020;8(2):112-121. |
26 | Royster E, Wagner S. Treatment of mastitis in cattle. Vet Clin North Am Food Anim Pract. 2015;31(1):17-46. DOI |
27 | Martinez PD, Cruz CA, Moreno FG. Resistance of causing bacteria of bovine mastitis in regard to common antimicrobials. Conexion Agropecuaria JDC. 2013;3(1):53-73. |
28 | de Almeida IC, Viana MVG, Dietrich WS, Clipes RC, Donatele DM, Martins IVF, et al. Economic impact of bovine mastitis in Espirito Santo, Brazil. Int J Dev Res. 2021;11(2):44315-44319. |
29 | Hillerton JE, Semmens JE. Comparison of treatment of mastitis by oxytocin or antibiotics following detection according to changes in milk electrical conductivity prior to visible signs. J Dairy Sci. 1999;82(1):93-98. DOI |
30 | Blondeau JM, Fitch SD. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis. PLoS One. 2019;14(1):e0210154. DOI |
31 | Kulkarni AG, Kaliwal BB. Bovine mastitis: a review. Int J Recent Sci Res. 2013;4(5):543-548. |
32 | Birhanu M, Leta S, Mamo G, Tesfaye S. Prevalence of bovine subclinical mastitis and isolation of its major causes in Bishoftu Town, Ethiopia. BMC Res Notes. 2017;10(1):767. DOI |
33 | Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother. 2006;50(11):3953-3955. DOI |
34 | Truchetti G, Bouchard E, Descoteaux L, Scholl D, Roy JP. Efficacy of extended intramammary ceftiofur therapy against mild to moderate clinical mastitis in Holstein dairy cows: a randomized clinical trial. Can J Vet Res. 2014;78(1):31-37. |
35 | Schalm OW, Noorlander DO. Experiments and observations leading to development of the California mastitis test. J Am Vet Med Assoc. 1957;130(5):199-204. |
36 | Viveros M, Lopez-Ordaz R, Gutierrez L, Miranda-Calderon JE, Sumano H. Efficacy assessment of an intramammary treatment with a new recrystallized enrofloxacin vs ceftiofur and parenteral enrofloxacin in dairy cows with nonsevere clinical mastitis. J Vet Pharmacol Ther. 2018;41(1):e1-e9. DOI |
37 | Procedure for Collecting Milk Samples [Internet]. New Prague: National Mastitis Council; http://www.nmconline.org. Update 2004. Accessed 2020 Oct 26. |
38 | Oram M, Kuroda R, Fisher LM. Escherichia coli DNA gyrase: genetic analysis of gyrA and gyrB mutations responsible for thermosensitive enzyme activity. FEBS Lett. 1992;312(1):61-65. DOI |